NYSE - Nasdaq Real Time Price USD

Abrdn Healthcare Investors (HQH)

Compare
16.06 -0.24 (-1.47%)
As of 11:40:08 AM EST. Market Open.

Key Executives

Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Daniel R. Omstead M.S, Ph.D. Portfolio Manager -- -- 1953
Dr. Jason C. Akus M.B.A., M.D., MBA Vice President of Research and Portfolio Manager -- -- --
Mr. Christopher F. Brinzey MBA Senior Vice President of Research and Portfolio Manager -- -- --
Dr. Frank T. Gentile Ph.D. Senior Vice President of Research and Portfolio Manager -- -- 1962

Abrdn Healthcare Investors

1900 Market Street
Suite 200
Philadelphia, PA 19103
United States
215 405 5700
Industry: 
Asset Management

Description

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Corporate Governance

Abrdn Healthcare Investors’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

December 16, 2024 at 12:00 AM UTC

N-CEN: Annual Report for Registered Investment Companies

December 9, 2024 at 12:00 AM UTC

N-CSR: Periodic Reports

November 27, 2024 at 12:00 AM UTC

NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)

November 21, 2024 at 12:00 AM UTC

Ex-Dividend Date

November 18, 2024 at 12:00 AM UTC

SC 13D/A: Tender Offer/Acquisition Reports

October 22, 2024 at 12:00 AM UTC

SC 13D/A: Tender Offer/Acquisition Reports

September 3, 2024 at 12:00 AM UTC

N-PX: Annual Report of Proxy Voting Record of Registered Management Investment Companies filed on Form N-PX

August 28, 2024 at 12:00 AM UTC

NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)

August 15, 2024 at 12:00 AM UTC

40-17G: Fidelity bond filed pursuant to Rule 17g1(g)(1) of the Investment Company Act of 1940

May 29, 2024 at 12:00 AM UTC

NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)

Related Tickers